BDBM291366 3-{4-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′,2′:4,5]furo[3,2-d]pyrimidin-8-ylmethyl]-piperazin-1-yl}-propionitrile::US9580442, Example R::US9938290, R
SMILES N#CCCN1CCN(Cc2cnc3oc4c(nc(nc4c3c2)-c2cccc3[nH]ccc23)N2CCOCC2)CC1
InChI Key InChIKey=RKURGBLIJFFUCK-UHFFFAOYSA-N
Data 8 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 8 hits for monomerid = 291366
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 597nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 131nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 22nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 2.54E+3nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 2.54E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair